Decoding immune‐driven erythroid failure in pure red cell aplasia
British Journal of Haematology · 2026-05 · 208 (5) · 1887-1889
DOI: 10.1111/bjh.70473 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 06.04.2026. Verfasst von Federico Spataro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision and Regenerative Medicine and Ionian Area - DiMePRe-J, Section of Pharmacology, University of Bari Aldo Moro, Bari, Italy. Hauptthemen laut MEDLINE: Red-Cell Aplasia, Pure. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian network of excellence for advanced diagnosis INNOVA, "Ministero della Salute" (code PNC-E3-2022-23683266 PNC-HLS-DA, to VD and AGS), European Union-Next Generation EU-PNRR M6C2- "Investimento 2.1 Potenziamento e rafforzamento della ricerca biomedica nel SSN" (project n. PNRR-POC-2022-1237586…, "Fondo per il Programma Nazionale di Ricerca e Progetti di Rilevante Interesse Nazionale - PRIN" (code 2022ZKKWLW to AGS).
Abstract (Originalsprache)
Pure red cell aplasia (PRCA) is increasingly recognised as a T‐cell‐mediated bone marrow failure syndrome, yet its immunogenetic drivers remain poorly defined. In their paper, Yamashita et al. integrate human leucocyte antigen (HLA) typing, T‐cell receptor repertoire analysis and mutational profiling to reveal enriched HLA alleles, signal transducer and activator of transcription 3 ( STAT3 )‐mutated T‐cell clones and a shared T cell receptor beta (TCRβ) motif in PRCA patients. These findings suggest that antigen‐driven cytotoxic T‐cell responses represent a central mechanism underlying erythroid suppression. Commentary on: Yamashita et al. Immunological features of acquired pure red cell aplasia: Specific human leucocyte antigen alleles, signal transducer and activator of transcription 3 mutations and a unique T‐ cell receptor beta motif. Br J Haematol 2026; 208:1797–1805.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Precision and Regenerative Medicine and Ionian Area - DiMePRe-J, Section of Pharmacology, University of Bari Aldo Moro, Bari, Italy.
- Department of Precision and Regenerative Medicine and Ionian Area - DiMePRe-J, Guido Baccelli Unit of Internal Medicine, School of Medicine, University of Bari Aldo Moro, Bari, Italy.
ORCID-Profile: Antonio Giovanni Solimando
Förderung
- Italian network of excellence for advanced diagnosis INNOVA, "Ministero della Salute" (code PNC-E3-2022-23683266 PNC-HLS-DA, to VD and AGS)
- European Union-Next Generation EU-PNRR M6C2- "Investimento 2.1 Potenziamento e rafforzamento della ricerca biomedica nel SSN" (project n. PNRR-POC-2022-1237586…
- "Fondo per il Programma Nazionale di Ricerca e Progetti di Rilevante Interesse Nazionale - PRIN" (code 2022ZKKWLW to AGS)
- "Società Italiana di Medicina Interna-SIMI" 2023 Research Award (Camel to AGS)
Zitieren
APA
Spataro, F., Desantis, V., & Solimando, A. G. (2026). Decoding immune‐driven erythroid failure in pure red cell aplasia. British Journal of Haematology, 208(5), 1887-1889. https://doi.org/10.1111/bjh.70473
Vancouver
Spataro F, Desantis V, Solimando AG. Decoding immune‐driven erythroid failure in pure red cell aplasia. British Journal of Haematology. 2026;208(5):1887-1889. doi:10.1111/bjh.70473
BibTeX
@article{Spataro2026,
author = {Spataro, Federico and Desantis, Vanessa and Solimando, Antonio Giovanni},
title = {Decoding immune‐driven erythroid failure in pure red cell aplasia},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {5},
pages = {1887--1889},
doi = {10.1111/bjh.70473}
}
EUVIMED